These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 27389451)

  • 21. Association of total cholesterol versus other serum lipid parameters with the short-term prediction of cardiovascular outcomes: Tehran Lipid and Glucose Study.
    Hadaegh F; Harati H; Ghanbarian A; Azizi F
    Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):571-7. PubMed ID: 16874147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Joint effect of high-density lipoprotein cholesterol and low-density lipoprotein cholesterol on the risk of coronary heart disease.
    Hu G; Cui Y; Jousilahti P; Sundvall J; Girman CJ; Antikainen R; Laatikainen T; Tuomilehto J
    Eur J Prev Cardiol; 2013 Feb; 20(1):89-97. PubMed ID: 22023802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Usefulness of Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol as Predictors of Cardiovascular Disease in Chinese.
    Gu X; Yang X; Li Y; Cao J; Li J; Liu X; Chen J; Shen C; Yu L; Huang J; Gu D
    Am J Cardiol; 2015 Oct; 116(7):1063-70. PubMed ID: 26250998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipid levels and the risk of ischemic stroke in women.
    Kurth T; Everett BM; Buring JE; Kase CS; Ridker PM; Gaziano JM
    Neurology; 2007 Feb; 68(8):556-62. PubMed ID: 17310025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipid profile components and incident cerebrovascular events versus coronary heart disease; the result of 9 years follow-up in Tehran Lipid and Glucose Study.
    Tohidi M; Mohebi R; Cheraghi L; Hajsheikholeslami F; Aref S; Nouri S; Azizi F; Hadaegh F
    Clin Biochem; 2013 Jun; 46(9):716-21. PubMed ID: 23531403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of Serum Lipids and Coronary Heart Disease in Contemporary Observational Studies.
    Colantonio LD; Bittner V; Reynolds K; Levitan EB; Rosenson RS; Banach M; Kent ST; Derose SF; Zhou H; Safford MM; Muntner P
    Circulation; 2016 Jan; 133(3):256-64. PubMed ID: 26659948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low levels of high-density lipoprotein cholesterol in patients with atherosclerotic stroke: a prospective cohort study.
    Yeh PS; Yang CM; Lin SH; Wang WM; Chen PS; Chao TH; Lin HJ; Lin KC; Chang CY; Cheng TJ; Li YH
    Atherosclerosis; 2013 Jun; 228(2):472-7. PubMed ID: 23618097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of Combined C-Reactive Protein and High-Density Lipoprotein Cholesterol Levels on Long-Term Outcomes in Patients With Coronary Artery Disease After a First Percutaneous Coronary Intervention.
    Ogita M; Miyauchi K; Tsuboi S; Shitara J; Endo H; Wada H; Doi S; Naito R; Konishi H; Dohi T; Kasai T; Tamura H; Okazaki S; Suwa S; Daida H
    Am J Cardiol; 2015 Oct; 116(7):999-1002. PubMed ID: 26243577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years.
    Krumholz HM; Seeman TE; Merrill SS; Mendes de Leon CF; Vaccarino V; Silverman DI; Tsukahara R; Ostfeld AM; Berkman LF
    JAMA; 1994 Nov; 272(17):1335-40. PubMed ID: 7772105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Usefulness of atherogenic dyslipidemia for predicting cardiovascular risk in patients with angiographically defined coronary artery disease.
    Arca M; Montali A; Valiante S; Campagna F; Pigna G; Paoletti V; Antonini R; Barillà F; Tanzilli G; Vestri A; Gaudio C
    Am J Cardiol; 2007 Nov; 100(10):1511-6. PubMed ID: 17996510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A revised definition of the metabolic syndrome predicts coronary artery disease and ischemic stroke after adjusting for low density lipoprotein cholesterol in a 13-year cohort study of Japanese: the Suita study.
    Okamura T; Kokubo Y; Watanabe M; Higashiyama A; Ono Y; Nishimura K; Okayama A; Miyamoto Y
    Atherosclerosis; 2011 Jul; 217(1):201-6. PubMed ID: 21481396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.
    Amarenco P; Goldstein LB; Callahan A; Sillesen H; Hennerici MG; O'Neill BJ; Rudolph AE; Simunovic L; Zivin JA; Welch KM;
    Atherosclerosis; 2009 Jun; 204(2):515-20. PubMed ID: 18962621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
    Goel PK; Bharti BB; Pandey CM; Singh U; Tewari S; Kapoor A; Garg N; Sinha N
    Indian Heart J; 2003; 55(3):234-40. PubMed ID: 14560932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apolipoprotein B improves risk assessment of future coronary heart disease in the Framingham Heart Study beyond LDL-C and non-HDL-C.
    Pencina MJ; D'Agostino RB; Zdrojewski T; Williams K; Thanassoulis G; Furberg CD; Peterson ED; Vasan RS; Sniderman AD
    Eur J Prev Cardiol; 2015 Oct; 22(10):1321-7. PubMed ID: 25633587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of low-density lipoprotein particle number distribution in patients with type 2 diabetes mellitus with low-density lipoprotein cholesterol <50 mg/dl and non-high-density lipoprotein cholesterol <80 mg/dl.
    Malave H; Castro M; Burkle J; Voros S; Dayspring T; Honigberg R; Pourfarzib R
    Am J Cardiol; 2012 Sep; 110(5):662-5. PubMed ID: 22621796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke: the Rotterdam Study.
    Oei HH; van der Meer IM; Hofman A; Koudstaal PJ; Stijnen T; Breteler MM; Witteman JC
    Circulation; 2005 Feb; 111(5):570-5. PubMed ID: 15699277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low high-density lipoprotein cholesterol is not a risk factor for recurrent vascular events in patients with vascular disease on intensive lipid-lowering medication.
    van de Woestijne AP; van der Graaf Y; Liem AH; Cramer MJ; Westerink J; Visseren FL;
    J Am Coll Cardiol; 2013 Nov; 62(20):1834-41. PubMed ID: 23948286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-density lipoprotein cholesterol and mortality in older people.
    Tikhonoff V; Casiglia E; Mazza A; Scarpa R; Thijs L; Pessina AC; Staessen JA
    J Am Geriatr Soc; 2005 Dec; 53(12):2159-64. PubMed ID: 16398902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Importance of high-density lipoprotein cholesterol levels in elderly diabetic individuals with type IIb dyslipidemia: A 2-year survey of cardiovascular events.
    Ina K; Hayashi T; Araki A; Kawashima S; Sone H; Watanabe H; Ohrui T; Yokote K; Takemoto M; Kubota K; Noda M; Noto H; Ding QF; Zhang J; Yu ZY; Yoon BK; Nomura H; Kuzuya M;
    Geriatr Gerontol Int; 2014 Oct; 14(4):806-10. PubMed ID: 24215618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.